M6A ‐Mediated Stabilization of RGS1 Drives Keloid Formation by Activating Inflammatory Response and Oxidative Stress
The FASEB Journal · 30.11.2026 · 40 (22)
DOI: 10.1096/fj.202603274r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 14.11.2026. Verfasst von Xianying Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China. Hauptthemen laut MEDLINE: RGS Proteins, Keloid, Oxidative Stress, Inflammation. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Quanzhou Municipal Science and Technology Program, Fujian Provincial Joint Funds for Science and Technology Innovation.
Abstract (Originalsprache)
Keloids are fibroproliferative skin disorders with limited therapeutic options. Epigenetic regulation, particularly N6‐methyladenosine (m6A) modification, along with inflammatory signaling, is increasingly implicated in their pathogenesis. By analyzing three keloid expression datasets (GSE151464, GSE212954, GSE188952), we identified regulator of G‐protein signaling 1 (RGS1) as a consistently upregulated target. Both RGS1 and the m6A methyltransferase METTL3 were significantly elevated in clinical keloid tissues and primary fibroblasts, showing a positive correlation. MeRIP‐qPCR confirmed abundant m6A modifications on RGS1 mRNA. Silencing METTL3 reduced m6A modification and stability of RGS1 mRNA, whereas RGS1 overexpression did not alter METTL3 levels. In keloid fibroblasts, RGS1 overexpression activated the NF‐κB pathway, enhanced the secretion of IL‐1β, TNF‐α, and IL‐6, elevated reactive oxygen species (ROS), and suppressed antioxidant proteins NQO1 and HO‐1. These effects were reversed by pyrrolidine dithiocarbamate (PDTC), an NF‐κB inhibitor. METTL3 knockdown also impaired fibroblast proliferation, migration, invasion, and reduced fibrosis markers α‐SMA, Vimentin, and COL1, all rescued by RGS1 overexpression. In a xenograft model, RGS1 overexpression accelerated lesion growth and systemic inflammation, which PDTC treatment attenuated. In summary, METTL3‐mediated m6A modification stabilizes RGS1 mRNA, promoting keloid progression through NF‐κB‐dependent inflammation and oxidative stress, highlighting the METTL3/RGS1/NF‐κB axis as a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
- Department of Dermatology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
- Department of Nuclear Medical, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
- Department of General Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
- Department of Thyroid and Breast Surgery, Jinjiang Municipal Hospital (Shanghai Sixth People's Hospital Fujian), Quanzhou, Fujian, China.
- Jinjiang Municipal Hospital Jinan Branch, Quanzhou, Fujian, China.
ORCID-Profile: Tianzi Hong
Förderung
- Quanzhou Municipal Science and Technology Program
- Fujian Provincial Joint Funds for Science and Technology Innovation
Zitieren
APA
Zhou, X., Pan, M., Xie, L., Xie, R., Lin, X., Lin, Y., Huang, Y., Hong, T., & Wang, C. (2026). M6A ‐Mediated Stabilization of RGS1 Drives Keloid Formation by Activating Inflammatory Response and Oxidative Stress. The FASEB Journal, 40(22). https://doi.org/10.1096/fj.202603274r
Vancouver
Zhou X, Pan M, Xie L, Xie R, Lin X, Lin Y, et al. M6A ‐Mediated Stabilization of RGS1 Drives Keloid Formation by Activating Inflammatory Response and Oxidative Stress. The FASEB Journal. 2026;40(22). doi:10.1096/fj.202603274r
BibTeX
@article{Zhou2026,
author = {Zhou, Xianying and Pan, Mingmeng and Xie, Long and Xie, Rongrong and Lin, Xingong and Lin, Yuping and Huang, Yanyan and Hong, Tianzi and Wang, Chaoyang},
title = {M6A ‐Mediated Stabilization of RGS1 Drives Keloid Formation by Activating Inflammatory Response and Oxidative Stress},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {22},
doi = {10.1096/fj.202603274r}
}
EUVIMED